Medscape12 小时
Sotagliflozin Not Approved as Type 1 Diabetes Add-On
The US Food and Drug Administration declined to approve the drug for people with type 1 diabetes and chronic kidney disease.
Minnesota’s insulin safety net is a critical resource, especially as the new year begins
High-deductible health insurance plans add a cost burden. Meanwhile, the circumstances of travel can lead to urgent needs.